Karnofsky Performance Status
"Karnofsky Performance Status" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.
MeSH Number(s)
E05.318.308.250.475.547.500
Concept/Terms
Karnofsky Performance Status- Karnofsky Performance Status
- Performance Status, Karnofsky
- Status, Karnofsky Performance
- Karnofsky Performance Status Scale
- Karnofsky Scale
- Scale, Karnofsky
- Karnofsky Index
- Index, Karnofsky
Below are MeSH descriptors whose meaning is more general than "Karnofsky Performance Status".
Below are MeSH descriptors whose meaning is more specific than "Karnofsky Performance Status".
This graph shows the total number of publications written about "Karnofsky Performance Status" by people in Harvard Catalyst Profiles by year, and whether "Karnofsky Performance Status" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 4 | 4 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 4 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 0 | 4 | 4 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 6 | 6 |
| 2010 | 1 | 4 | 5 |
| 2011 | 0 | 8 | 8 |
| 2012 | 1 | 5 | 6 |
| 2013 | 0 | 6 | 6 |
| 2014 | 0 | 8 | 8 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 5 | 5 |
| 2017 | 0 | 8 | 8 |
| 2018 | 2 | 7 | 9 |
| 2019 | 2 | 2 | 4 |
| 2020 | 1 | 5 | 6 |
| 2021 | 0 | 2 | 2 |
Below are the most recent publications written about "Karnofsky Performance Status" by people in Profiles.
-
Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone Metastases. Int J Radiat Oncol Biol Phys. 2022 01 01; 112(1):99-105.
-
Adverse Events in Neurosurgery: The Novel Therapy-Disability-Neurology Grade. Neurosurgery. 2021 07 15; 89(2):236-245.
-
Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors. Neurology. 2021 08 17; 97(7):e673-e683.
-
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients. Radiat Oncol. 2020 Dec 17; 15(1):282.
-
The Surgical Resection of Brainstem Glioma: Outcomes and Prognostic Factors. World Neurosurg. 2021 02; 146:e639-e650.
-
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient. J Clin Oncol. 2020 11 10; 38(32):3773-3784.
-
Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? Pancreatology. 2020 Jul; 20(5):952-959.
-
Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors. Cancer. 2020 05 15; 126(10):2288-2295.
-
Inter-rater reliability in performance status assessment among healthcare professionals: an updated systematic review and meta-analysis. Support Care Cancer. 2020 May; 28(5):2071-2078.
-
Inter-rater reliability in performance status assessment between clinicians and patients: a systematic review and meta-analysis. BMJ Support Palliat Care. 2020 Jun; 10(2):129-135.